TRVX: Targovax Reports Completion of Recruitment of Patients in the Phase I/II ...

TRVX: Targovax Reports Completion of Recruitment of Patients in the Phase I/II ...
Targovax was established in October in 2010 to develop immunotherapy in the form of therapeutic cancer vaccines based on pioneering research at the Norwegian Radium Hospital and Norsk Hydro. Mutation of RAS is an early mutation in the transformation ...
Read more on Rock Hill Herald (press release)




Newton Company Develops Prostate Cancer Vaccine
BOSTON (CBS) – Thomas Farrington was diagnosed with prostate cancer back in 2000. He underwent radiation therapy and was considered cancer free, but nine years later, it came back. “A recurrence is what no prostate cancer survivor wants to hear,” ...
Read more on CBS Local

0 Response to "TRVX: Targovax Reports Completion of Recruitment of Patients in the Phase I/II ..."

Post a Comment

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel